FAAH and breast cancer: Here, we unveil that (i) FAAH expression in BC is highly associated with luminal BC, where patients with low tumor FAAH levels show significantly worse overall survival; (ii) its expression in BC cells promotes a shift of the tumor phenotype towards a more differentiated state; and (iii) it reduces tumor progression and metastasis in cellular and mouse models of BC.